Jc elkas biography

Efficacy of endocervical curettage in colposcopic assessment of patients having abnormal squamous pap smear

Committee on Practice Bulletins - Gynecology. ACOG practice bulletin. Diagnosis and treatment of cervical carcinomas. Obstet Gynecol 2002;99:855-67.

Bidus MA, Elkas JC, Rodriguez M, Maxwell GL, Rose GS. The clinical utility of the diagnostic endocervical curettage. Clinical Obstet Ginecol 2005;48:202-8.

Williams DL, Dietrich C, McBroom J. Endocervical curettage when colposcopy examination is satisfactory and normal. Obstet Gynecol 2000;95:801-3.

Moniak CW, Kutzner S, Adam E, Harden J, Kaufman RH. Endocervical curettage in evaluation abnormal cervical cytology. J Reprod Med 2000;45:285-92.

Andersen W, Frierson H, Barber S, Tabbarah S, Taylor P, Underwood P. Sensitivity and specificity of endocervical curettage and the endocervical brush for the evaluation of the endocervical canal. Am J Obstet Gynecol 1988;159:702-7.

Dreyfus M, Baldauf JJ, Ritter J. Diagnostic value of endocervical curettage during colposcopy. Eur J Obstet Gynecol Reprod Biol 1996;64:101-4.

. Author manuscript; available in PMC: 2010 Oct 1.

Published in final edited form as: J Low Genit Tract Dis. 2009 Oct;13(4):216–223. doi: 10.1097/LGT.0b013e318195d91b

Abstract

Objective

To examine the utility of in vivo elastic light scattering measurements to identify cervical intraepithelial neoplasias (CIN) 2/3 and cancers in women undergoing colposcopy and to determine the effects of patient characteristics such as menstrual status on the elastic light scattering spectroscopic measurements.

Materials and Methods

A fiber optic probe was used to measure light transport in the cervical epithelium of patients undergoing colposcopy. Spectroscopic results from 151 patients were compared with histopathology of the measured and biopsied sites. A method of classifying the measured sites into two clinically relevant categories was developed and tested using five-fold cross-validation.

Results

Statistically significant effects by age at diagnosis, menopausal status, timing of the menstrual cycle, and oral contraceptive use were identified, and adjustments based upon these mea

Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination

  • Research
  • Open access
  • Published:
  • Jeremy D Goldhaber-Fiebert1,2,
  • Natasha K Stout1,2,
  • Jesse Ortendahl1,2,
  • Karen M Kuntz3,4,
  • Sue J Goldie1,2 &
  • Joshua A Salomon1,5,6

Population Health Metricsvolume 5, Article number: 11 (2007) Cite this article

  • 19k Accesses

  • 4 Altmetric

  • Metrics details

Abstract

Background

To provide quantitative insight into current U.S. policy choices for cervical cancer prevention, we developed a model of human papillomavirus (HPV) and cervical cancer, explicitly incorporating uncertainty about the natural history of disease.

Methods

We developed a stochastic microsimulation of cervical cancer that distinguishes different HPV types by their incidence, clearance, persistence, and progression. Input parameter sets were sampled randomly from uniform distributions, and simulations undertaken with each set. Through systematic reviews and formal data synthesis, we established multiple epidemiologic

Copyright ©cakestot.pages.dev 2025